These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20090379)

  • 41. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-related cognitive decline in patients with mood disorders.
    Gualtieri CT; Johnson LG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):962-7. PubMed ID: 18243461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological correlates of homocysteine levels in euthymic bipolar patients.
    Osher Y; Bersudsky Y; Silver H; Sela BA; Belmaker RH
    J Affect Disord; 2008 Jan; 105(1-3):229-33. PubMed ID: 17490752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homocysteine and cognitive function in a population-based study of older adults.
    Schafer JH; Glass TA; Bolla KI; Mintz M; Jedlicka AE; Schwartz BS
    J Am Geriatr Soc; 2005 Mar; 53(3):381-8. PubMed ID: 15743278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of homocysteine levels in the pathogenesis of cognitive disorders in patients with chronic cerebral ischemia].
    Fedin AI; Kaluga AS; Mironova OP; Solov'eva EIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):8-12. PubMed ID: 20879100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homocysteine in relation to cognitive performance in pathological and non-pathological conditions.
    Teunissen CE; van Boxtel MP; Jolles J; de Vente J; Vreeling F; Verhey F; Polman CH; Dijkstra CD; Blom HJ
    Clin Chem Lab Med; 2005; 43(10):1089-95. PubMed ID: 16197303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poor performance on cognitive tasks in depression: Doing too much or not enough?
    Jones NP; Siegle GJ; Muelly ER; Haggerty A; Ghinassi F
    Cogn Affect Behav Neurosci; 2010 Mar; 10(1):129-40. PubMed ID: 20233961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients.
    Reif A; Schneider MF; Kamolz S; Pfuhlmann B
    J Neural Transm (Vienna); 2003 Dec; 110(12):1401-11. PubMed ID: 14666412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactive effects of elevated homocysteine and late-life depression on cognitive impairment.
    Zhou H; Zhong X; Chen B; Wu Z; Zhang M; Mai N; Peng Q; Chen X; Ouyang C; Liang W; Dai C; Huang X; Zhang W; Ning Y
    J Affect Disord; 2020 Dec; 277():212-217. PubMed ID: 32829197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depression, Parkinson disease, Alzheimer disease. The homocysteine hypothesis.
    Sui R; Zhang L
    Neurosciences (Riyadh); 2010 Jul; 15(3):211-3. PubMed ID: 20831034
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between homocysteine, depression, and cognitive function in community-dwelling older women from Australia.
    Almeida OP; Lautenschlager N; Flicker L; Leedman P; Vasikaran S; Gelavis A; Ludlow J
    J Am Geriatr Soc; 2004 Feb; 52(2):327-8. PubMed ID: 14728657
    [No Abstract]   [Full Text] [Related]  

  • 52. 3-Deazaadenosine, a stabilizer of whole-blood homocysteine content, does not interfere with the single-enzyme homocysteine assay while totally inhibiting the enzyme conversion homocysteine immunoassay.
    Han Q; Sun X; Xu M; Zhang N; Tang L; Tan Y; Hoffman RM
    Clin Chem; 2004 Sep; 50(9):1703-4. PubMed ID: 15331515
    [No Abstract]   [Full Text] [Related]  

  • 53. High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term.
    Oner P; Yilmaz S; Doğan S
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrovascular disease and executive dysfunction in geriatric depression.
    Lucchi E; Bellelli G; Magnifico F; Guerini F; Trabucchi M
    J Gerontol A Biol Sci Med Sci; 2005 Dec; 60(12):1606. PubMed ID: 16424296
    [No Abstract]   [Full Text] [Related]  

  • 55. [Japanese-English technical terms on geriatric medicine].
    Ozawa T
    Nihon Ronen Igakkai Zasshi; 2001 May; 38(3):263-8. PubMed ID: 11431866
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased homocysteine in liver cirrhosis: a result of renal impairment?
    Woitas RP; Stoffel-Wagner B; Poege U; Sauerbruch T
    Clin Chem; 2002 May; 48(5):796-7; author reply 797-8. PubMed ID: 11978617
    [No Abstract]   [Full Text] [Related]  

  • 57. Cognitive Impairment in Geriatric Psychotic Depression: Unanswered Questions.
    Meyers BS
    Am J Geriatr Psychiatry; 2019 Dec; 27(12):1345-1347. PubMed ID: 31494014
    [No Abstract]   [Full Text] [Related]  

  • 58. Determination of total homocysteine.
    Pietzsch J; Pixa A
    Clin Chem; 1998 Aug; 44(8 Pt 1):1781-2. PubMed ID: 9702982
    [No Abstract]   [Full Text] [Related]  

  • 59. Corrigendum to "Slowed Processing Speed Disrupts Patient Expectancy in Late Life Depression" [The American Journal of Geriatric Psychiatry 29 (2021) 619-630].
    Rutherford BR; Jean Choi C; Choi J; Maas B; He X; O'Boyle K; Sneed J; Brown PJ; Brickman A; Wall MM; Roose SP
    Am J Geriatr Psychiatry; 2023 Jan; 31(1):78-79. PubMed ID: 36280536
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevalence of depression and cognitive deficit in a geriatric population.
    Silverstri A; Visconti G; Fini M; Pagano S; Cisternino D; Mochi M; Cavazzini C; Landoni F; Lauro R
    Arch Gerontol Geriatr Suppl; 2001; 7():351-5. PubMed ID: 11431085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.